ALLO vs CLOV
Allogene Therapeutics Inc (ALLO) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
ALLO currently screens at market cap $258.1M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the ALLO and CLOV stock pages for the full models.
Not investment advice.